Evolution of a Synthetic Strategy: Total Synthesis of (±)-Welwitindolinone A Isonitrile
Abstract
An efficient and highly stereoselective total synthesis of the natural product (±)-welwitindolinone A isonitrile (1) is described. The bicyclo[4.2.0]octane core of 1 was established by a regio- and diastereoselective [2+2] ketene cycloaddition. The C12 quaternary center and vicinal stereogenic chlorine were installed in a single operation with excellent stereocontrol via a chloronium ion mediated semipinacol rearrangement. Described strategies for construction of the spiro-oxinole include a SmI_2−LiCl mediated reductive cyclization and a novel anionic cyclization that simultaneously constructs the spiro-oxindole and vinyl isonitrile moieties.
Additional Information
© 2008 American Chemical Society. Received September 19, 2007; Publication Date (Web): January 17, 2008. Financial support was provided by Bristol-Myers Squibb, Yamanouchi, Merck, Amgen, Pfizer, and the NIH (Grant No. 1 RO1 CA/GM 93591-01A). S.E.R. thanks Bristol-Myers Squibb for a graduate student fellowship. J.M.R. was the recipient of a NIH postdoctoral fellowship. In addition, we acknowledge and thank C.D. Incarvito for X-ray crystallographic analysis.Attached Files
Supplemental Material - ja076663z-file003.cif
Supplemental Material - ja076663z-file004.cif
Supplemental Material - ja076663z-file005.cif
Supplemental Material - ja076663z-file006.cif
Supplemental Material - ja076663z-file007.cif
Supplemental Material - ja076663z-file008.cif
Supplemental Material - ja076663z-file010.pdf
Supplemental Material - ja076663z-file011.pdf
Files
Name | Size | Download all |
---|---|---|
md5:555d4c5cdfa8fb9a0484c194b12fa3b0
|
13.1 kB | Download |
md5:117c00744adb572d36c325ed90340779
|
13.3 kB | Download |
md5:844f8a4859a753e5472fad6be6b8341f
|
13.3 kB | Download |
md5:04db218c608ffaf685f4315b73a88089
|
20.6 kB | Download |
md5:f13752a5ff5d431ef1de9b0a6c17c1c4
|
19.2 kB | Download |
md5:380776eae3472bd636720f44f1d8aaf2
|
19.4 MB | Preview Download |
md5:76d65e248f3220e23044b11239d31fa0
|
15.6 kB | Download |
md5:8bf80aaa56c1e68595b49b9e105c4cc3
|
2.5 MB | Preview Download |
Additional details
- Eprint ID
- 75606
- Resolver ID
- CaltechAUTHORS:20170331-150127498
- Bristol-Myers Squibb
- Yamanouchi
- Merck
- Amgen
- Pfizer
- NIH
- 1 RO1 CA/GM 93591-01A
- NIH Postdoctoral Fellowship
- Created
-
2017-04-03Created from EPrint's datestamp field
- Updated
-
2021-11-15Created from EPrint's last_modified field